Profiel
Johan Lindh is the founder of Aptahem AB, a company founded in 2014.
He holds the title of Director at Aptahem AB.
Dr. Lindh's current job is at the University of Uppsala, where he started in 2014 and is currently an Associate Professor.
Dr. Lindh obtained a doctorate degree from Imperial College London.
Actieve functies van Johan Lindh
Bedrijven | Functie | Begin |
---|---|---|
Aptahem AB
Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Oprichter | 01-01-2014 |
University of Uppsala | Corporate Officer/Principal | 01-01-2014 |
Opleiding van Johan Lindh
Imperial College London | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
Health Technology |